2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Sell
19
CRSP Quote, Financials, Valuation and Earnings
Last price:
$42.81
Seasonality move
:
6.36%
Day range:
$41.94 - $43.48
52-week range:
$36.52 - $75.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.87x
Volume:
1.4M
Avg. volume:
2.4M
1-year change:
-41.51%
Market cap:
$3.6B
Revenue:
$35M
EPS (TTM):
-$4.37
CRISPR Therapeutics AG SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
CRSP
CRISPR Therapeutics AG
|
11/06/2023 | 10-Q | 10-Q filing on 11/06/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/07/2023 | 10-Q | 10-Q filing on 08/07/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/08/2023 | 10-Q | 10-Q filing on 05/08/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/01/2022 | 10-Q | 10-Q filing on 11/01/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/08/2022 | 10-Q | 10-Q filing on 08/08/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/09/2022 | 10-Q | 10-Q filing on 05/09/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/03/2021 | 10-Q | 10-Q filing on 11/03/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/27/2021 | 10-Q | 10-Q filing on 04/27/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/16/2021 | 10-K | 10-K filing on 02/16/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
10/28/2020 | 10-Q | 10-Q filing on 10/28/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/27/2020 | 10-Q | 10-Q filing on 07/27/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/28/2020 | 10-Q | 10-Q filing on 04/28/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/12/2020 | 10-K | 10-K filing on 02/12/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
10/28/2019 | 10-Q | 10-Q filing on 10/28/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/29/2019 | 10-Q | 10-Q filing on 07/29/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/29/2019 | 10-Q | 10-Q filing on 04/29/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/25/2019 | 10-K | 10-K filing on 02/25/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/07/2018 | 10-Q | 10-Q filing on 11/07/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/08/2018 | 10-Q | 10-Q filing on 05/08/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
03/08/2018 | 10-K | 10-K filing on 03/08/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/08/2017 | 10-Q | 10-Q filing on 11/08/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/10/2017 | 10-Q | 10-Q filing on 08/10/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/11/2017 | 10-Q | 10-Q filing on 05/11/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
03/10/2017 | 10-K | 10-K filing on 03/10/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/22/2016 | 10-Q | 10-Q filing on 11/22/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Is Goldman Sachs Stock a Buy Sell or Hold?
When the Federal Reserve started hiking rates in 2022, banks’…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
49
SMTC alert for Mar 17
Semtech [SMTC] is down 0.49% over the past day.
Buy
62
PLPC alert for Mar 17
Preformed Line Products [PLPC] is up 3.8% over the past day.
Sell
50
NUTX alert for Mar 17
Nutex Health [NUTX] is up 4.82% over the past day.
